Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
School of Medicine, LSU Health New Orleans, New Orleans, Louisiana, USA.
Obesity (Silver Spring). 2021 Jun;29(6):954-959. doi: 10.1002/oby.23161.
Obesity and type 2 diabetes are both chronic, relapsing, progressive diseases that are recognized as risk factors for the development of multiple types of cancer. In a recent symposium titled "Hitting A Triple-Diabetes, Obesity, and the Emerging Links to Cancer Risk," convened by The Obesity Society during ObesityWeek 2019, experts in the field presented the current science and highlighted existing research gaps. Topics included (1) the epidemiology of obesity and diabetes and their links to cancer risk; (2) racial and ethnic differences in obesity, diabetes, and cancer risk; (3) biological mechanisms common to obesity and diabetes that may increase cancer risk; and (4) innovative interventions that can be used to prevent the development of cancers related to obesity and diabetes. This report provides an overview of the symposium and describes key research gaps and pressing questions in need of answers to advance the field. The collective burden of obesity, diabetes, and cancer represents one of the largest public health challenges of the century. Although the symposium was titled "hitting a triple," it was recognized that being able to disrupt the linkages among obesity, diabetes, and cancer would be a "grand slam" for public health and medicine.
肥胖症和 2 型糖尿病都是慢性、复发性、进行性疾病,被认为是多种癌症发生的危险因素。在 2019 年肥胖周期间,肥胖协会召开了一次题为“打击三重奏——糖尿病、肥胖症和癌症风险的新关联”的专题研讨会,该领域的专家介绍了目前的科学进展,并强调了现有研究差距。讨论的主题包括:(1)肥胖症和糖尿病的流行病学及其与癌症风险的关联;(2)肥胖症、糖尿病和癌症风险方面的种族和民族差异;(3)肥胖症和糖尿病共有的可能增加癌症风险的生物学机制;(4)用于预防与肥胖症和糖尿病相关癌症发生的创新干预措施。本报告概述了专题研讨会的内容,并描述了该领域需要解决的关键研究差距和紧迫问题。肥胖症、糖尿病和癌症的共同负担是本世纪最大的公共卫生挑战之一。尽管研讨会的标题是“打击三重奏”,但与会者认识到,打破肥胖症、糖尿病和癌症之间的联系将是公共卫生和医学领域的“大满贯”。